BRILLANTI, STEFANO
BRILLANTI, STEFANO
DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE
Evaluation of Drug Interactions in Patients Treated with DAAs for Hepatitis C Therapy with Comorbidities and Cardiovascular Issues-A Delphi Consensus Project
2022 Borghi C, Ciancio A, Gentile I, Perrone Filardi P, Pasqualetti P, Brillanti S.
Spleen Stiffness Measurements Predict the Risk of Hepatic Decompensation after Direct-Acting Antivirals in HCV Cirrhotic Patients
2022 Dajti, E.; Ravaioli, F.; Colecchia, A.; Marasco, G.; Bacchi Reggiani, M. L.; Colli, A.; Alemanni, L. V.; Tame, M.; Andreone, P.; Brillanti, S.; Azzaroli, F.; Mazzella, G.; Festi, D.
A multimedia multilanguage web-based platform can assess and increase the awareness on HCV infection of Pakistani people living in Italy
2021 Frazzoni, L.; Sikandar, U.; Mazzella, G.; Fuccio, L.; Bazzoli, F.; Brillanti, S.; Azzaroli, F.
HEPATIC DECOMPENSATION RISK IS REDUCED, BUT NOT ELIMINATED AFTER DIRECT-ACTING ANTIVIRALS: THE ROLE OF SPLEEN STIFFNESS MEASUREMENT
2019 Marasco, G; Dajti, E; Ravaioli, F; Colecchia, A; Reggiani, MLB; Colli, A; Alemanni, LV; Tame, MR; Andreone, P; Brillanti, S; Azzaroli, F; Mazzella, G; Festi, D
Immune inflammation indicators and ALBI score to predict liver cancer in HCV-patients treated with direct-acting antivirals
2019 Casadei Gardini, Andrea; Foschi, Francesco Giuseppe; Conti, Fabio; Petracci, Elisabetta; Vukotic, Ranka; Marisi, Giorgia; Buonfiglioli, Federica; Vitale, Giovanni; Ravaioli, Federico; Gitto, Stefano; Verucchi, Gabriella; Lenzi, Marco; Bolondi, Luigi; Mazzella, Giuseppe; Brillanti, Stefano; Andreone, Pietro*
Indocyanine green retention test predict the risk of portal hypertension-related events after direct-acting antiviral therapy in compensated advanced chronic liver disease patients
2019 Ravaioli, F.; Dajti, E.; Simoni, P.; Porro, A.; Marasco, G.; Alemanni, L.V.; Tamè, M.; Brillanti, S.; Colecchia, A.; Montagnani, M.; Festi, D.; Mazzella, G.; Azzaroli, F.
Direct antiviral therapy for hepatitis C and hepatocellular carcinoma: facing the conundrum
2018 Buonfiglioli, Federica; Brillanti, Stefano
Hepatocellular carcinoma risk assessment by the measurement of liver stiffness variations in HCV cirrhotics treated with direct acting antivirals
2018 Ravaioli, Federico; Conti, Fabio; Brillanti, Stefano; Andreone, Pietro; Mazzella, Giuseppe; Buonfiglioli, Federica; Serio, Ilaria; Verucchi, Gabriella ; Bacchi Reggiani, Maria Letizia; Colli, Agostino; Marasco, Giovanni; Colecchia, Antonio; Festi, Davide*
Imaging features of microvascular invasion in hepatocellular carcinoma developed after direct-acting antiviral therapy in HCV-related cirrhosis
2018 Renzulli, Matteo; Buonfiglioli, Federica; Conti, Fabio; Brocchi, Stefano; Serio, Ilaria; Foschi, Francesco Giuseppe; Caraceni, Paolo; Mazzella, Giuseppe; Verucchi, Gabriella; Golfieri, Rita; Andreone, Pietro; Brillanti, Stefano
Imbalance of Neutrophils and Lymphocyte Counts Can Be Predictive of Hepatocellular Carcinoma Occurrence in Hepatitis C-related Cirrhosis Treated With Direct-acting Antivirals
2018 Casadei Gardini, Andrea; Conti, Fabio; Foschi, Francesco Giuseppe; Brillanti, Stefano; Andreone, Pietro; Mazzella, Giuseppe; Ravaioli, Federico; Buonfiglioli, Federica; Bolondi, Luigi; Crespi, Cristina; Lenzi, Marco; Muratori, Paolo; Verucchi, Gabriella; Badia, Lorenzo; Bernardi, Mauro; Caraceni, Paolo; Morelli, Maria Cristina; Berardi, Sonia
Spleen stiffness decrease as mirror of portal hypertension changes after successful interferon-free therapy in chronic-HCV patients
2018 Ravaioli, F.; Dajti, E.; Colecchia, A.; Alemanni, V.; Marasco, G.; Tamé, M.; Azzaroli, F.; Brillanti, S.; Mazzella, G.; Festi, D.
Spleen stiffness mirrors changes in portal hypertension after successful interferon-free therapy in chronic-hepatitis C virus patients
2018 Ravaioli, Federico; Colecchia, Antonio; Dajti, Elton; Marasco, Giovanni; Alemanni, Luigina Vanessa; Tamè, Mariarosa; Azzaroli, Francesco; Brillanti, Stefano; Mazzella, Giuseppe; Festi, Davide
Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: Predictive role in HCC development in cirrhotic patients
2017 Ravaioli, F.; Mazzella, G.; Andreone, P.; Conti, F.; Brillanti, S.; Buonfiglioli, F.; Serio, I.; Verucchi, G.; Bacchi Reggiani, M.L.; Marasco, G.; Colecchia, A.; Festi, D.
Safety and efficacy of direct-acting antivirals for the treatment of chronic hepatitis C in a real-world population aged 65 years and older
2017 Conti, F.; Brillanti, S.; Buonfiglioli, F.; Vukotic, R.; Morelli, M.C.; Lalanne, C.; Massari, M.; Foschi, F.G.; Bernabucci, V.; Serio, I.; Prati, G.M.; Negri, E.; Badia, L.; Caraceni, P.; Muratori, P.; Vitale, G.; Porro, A.; Morotti, M.; Mazzella, G.; Andreone, P.
Spleen stiffness measurement: A useful prognostic tool in HCV patients treated with DAAs regimens
2017 Ravaioli, F.; Marasco, G.; Bacchi Reggiani, M.L.; Mazzella, G.; Buonfiglioli, F.; Porro, A.; Brillanti, S.; Colecchia, A.; Festi, D.
The Italian compassionate use of sofosbuvir observational cohort study for the treatment of recurrent hepatitis C: clinical and virological outcomes
2017 Carrai, Paola; Cristina, Morelli; Cordone, Gabriella; Romano, Antonietta; Tamã©, Mariarosa; Lionetti, Raffaella; Pietrosi, Giada; Lenci, Ilaria; Piai, Guido; Russo, Francesco Paolo; Coppola, Carmine; Melazzini, Mario; Montilla, Simona; Pani, Luca; Petraglia, Sandra; Russo, Pierluigi; Trotta, Maria Paola; Martini, Silvia; Toniutto, Pierluigi; Bandiera, Francesco; Bhoori, Sherrie; Brillanti, Stefano; Burra, Patrizia; Corsale, Sveva; De Luca, Andrea; Fagiuoli, Stefano; Fattovich, Giovanna; Fava, Gianmarco; Felder, Martina; Forte, Paolo; Galeota-Lanza, Alfonso; Gitto, Stefano; Grieco, Antonio; Grossi, Paolo; Ialungo, A. M.; Iemmolo, Rosa Maria; Loiacono, Laura; Mangia, Alessandra; Merli, Manuela; Piacentini, A.; Pellicelli, Adriano; Rigamonti, Cristina; Gabriella, Verucchi; Zignego, Anna Linda
THU-490 - Spleen stiffness measurement: a useful prognostic tool in HCV patients treated with DAAs regimens
2017 Ravaioli, F.; Marasco, G.; Reggiani, M.L.B.; Mazzella, G.; Buonfiglioli, F.; Porro, A.; Brillanti, S.; Colecchia, A.; Festi, D.
THU-492 - Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: predictive role in hepatocellular carcinoma development in in cirrhotic patients
2017 Ravaioli, F.; Mazzella, G.; Andreone, P.; Conti, F.; Brillanti, S.; Buonfiglioli, F.; Serio, I.; Verucchi, G.; Reggiani, M.L.B.; Marasco, G.; Colecchia, A.; Festi, D.
DEVELOPMENT OF HEPATOCELLULAR CARCINOMA IN HCV CIRRHOTIC PATIENTS TREATED WITH DIRECT ACTING ANTIVIRALS
2016 Buonfiglioli, F; Conti, F; Andreone, P; Crespi, C; Foschi, Fg; Lenzi, M; Mazzella, G; Verucchi, G; Brillanti, S
Direct acting antivirals for the treatment of elderly patients with HCV advanced disease in the real life practice
2016 Conti, F.; Scuteri, A.; Vitale, G.; Lazzarini, G.; Porro, A.; Muratori, P.; Serio, I.; Buonfiglioli, F.; Badia, L.; Lanzi, A.; Mastroroberto, M.; Appolloni, L.; Morotti, M.; Morelli, M.C.; Foschi, F.G.; Verucchi, G.; Brillanti, S.; Crespi, C.; Lenzi, M.; Mazzella, G.; Andreone, P.
Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
---|---|---|---|---|---|---|
Evaluation of Drug Interactions in Patients Treated with DAAs for Hepatitis C Therapy with Comorbidities and Cardiovascular Issues-A Delphi Consensus Project | Borghi C, Ciancio A, Gentile I, Perrone Filardi P, Pasqualetti P, Brillanti S. | 2022-01-01 | JOURNAL OF CLINICAL MEDICINE | - | 1.01 Articolo in rivista | Borghi C_Evaluation of drug interactions_J Clin Med.pdf; jcm-11-06946-s001.zip |
Spleen Stiffness Measurements Predict the Risk of Hepatic Decompensation after Direct-Acting Antivirals in HCV Cirrhotic Patients | Dajti, E.; Ravaioli, F.; Colecchia, A.; Marasco, G.; Bacchi Reggiani, M. L.; Colli, A.; Alemanni,... L. V.; Tame, M.; Andreone, P.; Brillanti, S.; Azzaroli, F.; Mazzella, G.; Festi, D. | 2022-01-01 | ULTRASCHALL IN DER MEDIZIN | - | 1.01 Articolo in rivista | 2. Manuscript_DAA_HD_Ultraschall_Rev2_clean.pdf |
A multimedia multilanguage web-based platform can assess and increase the awareness on HCV infection of Pakistani people living in Italy | Frazzoni, L.; Sikandar, U.; Mazzella, G.; Fuccio, L.; Bazzoli, F.; Brillanti, S.; Azzaroli, F. | 2021-01-01 | JOURNAL OF VIRAL HEPATITIS | - | 1.01 Articolo in rivista | - |
HEPATIC DECOMPENSATION RISK IS REDUCED, BUT NOT ELIMINATED AFTER DIRECT-ACTING ANTIVIRALS: THE ROLE OF SPLEEN STIFFNESS MEASUREMENT | Marasco, G; Dajti, E; Ravaioli, F; Colecchia, A; Reggiani, MLB; Colli, A; Alemanni, LV; Tame, MR;... Andreone, P; Brillanti, S; Azzaroli, F; Mazzella, G; Festi, D | 2019-01-01 | GUT | BMJ PUBLISHING GROUP | 4.01 Contributo in Atti di convegno | - |
Immune inflammation indicators and ALBI score to predict liver cancer in HCV-patients treated with direct-acting antivirals | Casadei Gardini, Andrea; Foschi, Francesco Giuseppe; Conti, Fabio; Petracci, Elisabetta; Vukotic,... Ranka; Marisi, Giorgia; Buonfiglioli, Federica; Vitale, Giovanni; Ravaioli, Federico; Gitto, Stefano; Verucchi, Gabriella; Lenzi, Marco; Bolondi, Luigi; Mazzella, Giuseppe; Brillanti, Stefano; Andreone, Pietro* | 2019-01-01 | DIGESTIVE AND LIVER DISEASE | - | 1.01 Articolo in rivista | - |
Indocyanine green retention test predict the risk of portal hypertension-related events after direct-acting antiviral therapy in compensated advanced chronic liver disease patients | Ravaioli, F.; Dajti, E.; Simoni, P.; Porro, A.; Marasco, G.; Alemanni, L.V.; Tamè, M.; Brillanti,... S.; Colecchia, A.; Montagnani, M.; Festi, D.; Mazzella, G.; Azzaroli, F. | 2019-01-01 | DIGESTIVE AND LIVER DISEASE | - | 4.02 Riassunto (Abstract) | - |
Direct antiviral therapy for hepatitis C and hepatocellular carcinoma: facing the conundrum | Buonfiglioli, Federica; Brillanti, Stefano | 2018-01-01 | HEPATOMA RESEARCH | - | 1.01 Articolo in rivista | - |
Hepatocellular carcinoma risk assessment by the measurement of liver stiffness variations in HCV cirrhotics treated with direct acting antivirals |
Ravaioli, Federico; Conti, Fabio; Brillanti, Stefano; Andreone, Pietro; Mazzella, Giuseppe; Buonf...iglioli, Federica; Serio, Ilaria; Verucchi, Gabriella ; Bacchi Reggiani, Maria Letizia; Colli, Agostino; Marasco, Giovanni; Colecchia, Antonio; Festi, Davide* |
2018-01-01 | DIGESTIVE AND LIVER DISEASE | - | 1.01 Articolo in rivista | - |
Imaging features of microvascular invasion in hepatocellular carcinoma developed after direct-acting antiviral therapy in HCV-related cirrhosis | Renzulli, Matteo; Buonfiglioli, Federica; Conti, Fabio; Brocchi, Stefano; Serio, Ilaria; Foschi, ...Francesco Giuseppe; Caraceni, Paolo; Mazzella, Giuseppe; Verucchi, Gabriella; Golfieri, Rita; Andreone, Pietro; Brillanti, Stefano | 2018-01-01 | EUROPEAN RADIOLOGY | - | 1.01 Articolo in rivista | - |
Imbalance of Neutrophils and Lymphocyte Counts Can Be Predictive of Hepatocellular Carcinoma Occurrence in Hepatitis C-related Cirrhosis Treated With Direct-acting Antivirals | Casadei Gardini, Andrea; Conti, Fabio; Foschi, Francesco Giuseppe; Brillanti, Stefano; Andreone, ...Pietro; Mazzella, Giuseppe; Ravaioli, Federico; Buonfiglioli, Federica; Bolondi, Luigi; Crespi, Cristina; Lenzi, Marco; Muratori, Paolo; Verucchi, Gabriella; Badia, Lorenzo; Bernardi, Mauro; Caraceni, Paolo; Morelli, Maria Cristina; Berardi, Sonia | 2018-01-01 | GASTROENTEROLOGY | - | 1.04 Replica / breve intervento (e simili) | - |
Spleen stiffness decrease as mirror of portal hypertension changes after successful interferon-free therapy in chronic-HCV patients | Ravaioli, F.; Dajti, E.; Colecchia, A.; Alemanni, V.; Marasco, G.; Tamé, M.; Azzaroli, F.; Brilla...nti, S.; Mazzella, G.; Festi, D. | 2018-01-01 | JOURNAL OF HEPATOLOGY | - | 1.06 Abstract in rivista | - |
Spleen stiffness mirrors changes in portal hypertension after successful interferon-free therapy in chronic-hepatitis C virus patients | Ravaioli, Federico; Colecchia, Antonio; Dajti, Elton; Marasco, Giovanni; Alemanni, Luigina Vaness...a; Tamè, Mariarosa; Azzaroli, Francesco; Brillanti, Stefano; Mazzella, Giuseppe; Festi, Davide | 2018-01-01 | WORLD JOURNAL OF HEPATOLOGY | - | 1.01 Articolo in rivista | - |
Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: Predictive role in HCC development in cirrhotic patients | Ravaioli, F.; Mazzella, G.; Andreone, P.; Conti, F.; Brillanti, S.; Buonfiglioli, F.; Serio, I.; ...Verucchi, G.; Bacchi Reggiani, M.L.; Marasco, G.; Colecchia, A.; Festi, D. | 2017-01-01 | DIGESTIVE AND LIVER DISEASE | - | 1.06 Abstract in rivista | - |
Safety and efficacy of direct-acting antivirals for the treatment of chronic hepatitis C in a real-world population aged 65 years and older | Conti, F.; Brillanti, S.; Buonfiglioli, F.; Vukotic, R.; Morelli, M.C.; Lalanne, C.; Massari, M.;... Foschi, F.G.; Bernabucci, V.; Serio, I.; Prati, G.M.; Negri, E.; Badia, L.; Caraceni, P.; Muratori, P.; Vitale, G.; Porro, A.; Morotti, M.; Mazzella, G.; Andreone, P. | 2017-01-01 | JOURNAL OF VIRAL HEPATITIS | - | 1.01 Articolo in rivista | - |
Spleen stiffness measurement: A useful prognostic tool in HCV patients treated with DAAs regimens | Ravaioli, F.; Marasco, G.; Bacchi Reggiani, M.L.; Mazzella, G.; Buonfiglioli, F.; Porro, A.; Bril...lanti, S.; Colecchia, A.; Festi, D. | 2017-01-01 | DIGESTIVE AND LIVER DISEASE | - | 1.06 Abstract in rivista | - |
The Italian compassionate use of sofosbuvir observational cohort study for the treatment of recurrent hepatitis C: clinical and virological outcomes | Carrai, Paola; Cristina, Morelli; Cordone, Gabriella; Romano, Antonietta; Tamã©, Mariarosa; Lione...tti, Raffaella; Pietrosi, Giada; Lenci, Ilaria; Piai, Guido; Russo, Francesco Paolo; Coppola, Carmine; Melazzini, Mario; Montilla, Simona; Pani, Luca; Petraglia, Sandra; Russo, Pierluigi; Trotta, Maria Paola; Martini, Silvia; Toniutto, Pierluigi; Bandiera, Francesco; Bhoori, Sherrie; Brillanti, Stefano; Burra, Patrizia; Corsale, Sveva; De Luca, Andrea; Fagiuoli, Stefano; Fattovich, Giovanna; Fava, Gianmarco; Felder, Martina; Forte, Paolo; Galeota-Lanza, Alfonso; Gitto, Stefano; Grieco, Antonio; Grossi, Paolo; Ialungo, A. M.; Iemmolo, Rosa Maria; Loiacono, Laura; Mangia, Alessandra; Merli, Manuela; Piacentini, A.; Pellicelli, Adriano; Rigamonti, Cristina; Gabriella, Verucchi; Zignego, Anna Linda | 2017-01-01 | TRANSPLANT INTERNATIONAL | - | 1.01 Articolo in rivista | - |
THU-490 - Spleen stiffness measurement: a useful prognostic tool in HCV patients treated with DAAs regimens | Ravaioli, F.; Marasco, G.; Reggiani, M.L.B.; Mazzella, G.; Buonfiglioli, F.; Porro, A.; Brillanti..., S.; Colecchia, A.; Festi, D. | 2017-01-01 | JOURNAL OF HEPATOLOGY | - | 1.06 Abstract in rivista | - |
THU-492 - Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: predictive role in hepatocellular carcinoma development in in cirrhotic patients | Ravaioli, F.; Mazzella, G.; Andreone, P.; Conti, F.; Brillanti, S.; Buonfiglioli, F.; Serio, I.; ...Verucchi, G.; Reggiani, M.L.B.; Marasco, G.; Colecchia, A.; Festi, D. | 2017-01-01 | JOURNAL OF HEPATOLOGY | - | 1.06 Abstract in rivista | - |
DEVELOPMENT OF HEPATOCELLULAR CARCINOMA IN HCV CIRRHOTIC PATIENTS TREATED WITH DIRECT ACTING ANTIVIRALS | Buonfiglioli, F; Conti, F; Andreone, P; Crespi, C; Foschi, Fg; Lenzi, M; Mazzella, G; Verucchi, G...; Brillanti, S | 2016-01-01 | JOURNAL OF HEPATOLOGY | - | 1.06 Abstract in rivista | - |
Direct acting antivirals for the treatment of elderly patients with HCV advanced disease in the real life practice | Conti, F.; Scuteri, A.; Vitale, G.; Lazzarini, G.; Porro, A.; Muratori, P.; Serio, I.; Buonfiglio...li, F.; Badia, L.; Lanzi, A.; Mastroroberto, M.; Appolloni, L.; Morotti, M.; Morelli, M.C.; Foschi, F.G.; Verucchi, G.; Brillanti, S.; Crespi, C.; Lenzi, M.; Mazzella, G.; Andreone, P. | 2016-01-01 | DIGESTIVE AND LIVER DISEASE | - | 1.06 Abstract in rivista | - |